“…At the same time, however, reports appeared that describe the appearance of malaria-producing plasmodium species resistant against artemisinin and artemisinin-derivatives [53,54]. Three approaches currently try to deal with this fatal trend: a) artemisinin combination therapy (ACT, with other non-peroxidic antimalarial drugs) [55], b) new peroxidic substances following the structural prototype [56,57], c) dyade concepts [58] involving structure combinations of two artemisinin monomers [59], artemisinin and quinolines [60], or artemisinin derivatives with synthetic 1,2,4-trioxane structures [61,62]. In this context, also the natural endoperoxide ascaridole was described as one potential dyade partner molecule [63].…”